Idexx Laboratories Inc (IDXX)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$8.20 (+1.92%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Idexx Laboratories Inc (IDXX)
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Key Insights

Critical company metrics and information
  • Share Price

    $435.69
  • Market Cap

    $35.68 Billion
  • Total Outstanding Shares

    81.89 Million Shares
  • Total Employees

    11,000
  • Dividend

    No dividend
  • IPO Date

    June 21, 1991
  • SIC Description

    In Vitro & In Vivo Diagnostic Substances
  • Homepage

    https://www.idexx.com

Historical Stock Splits

If you bought 1 share of IDXX before November 27, 2007, you'd have 4 shares today.
Execution DateSplit Amount
June 16, 20152-for-1
November 27, 20072-for-1

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow, Continuing$-27.96 Million
Net Cash Flow From Financing Activities, Continuing$-747.13 Million
Net Cash Flow From Operating Activities$916.83 Million
Net Cash Flow From Investing Activities, Continuing$-197.65 Million
Exchange Gains/Losses$4.90 Million
Net Cash Flow From Financing Activities$-747.13 Million
Net Cash Flow$-23.06 Million
Net Cash Flow From Investing Activities$-197.65 Million
Net Cash Flow From Operating Activities, Continuing$916.83 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Research and Development$213.88 Million
Preferred Stock Dividends And Other Adjustments$0.00
Benefits Costs and Expenses$2.75 Billion
Net Income/Loss Attributable To Parent$866.24 Million
Revenues$3.84 Billion
Net Income/Loss Available To Common Stockholders, Basic$866.24 Million
Income Tax Expense/Benefit, Deferred$-62.43 Million
Gross Profit$2.33 Billion
Costs And Expenses$2.75 Billion
Basic Earnings Per Share$10.46
Other Operating Expenses$1.01 Billion
Net Income/Loss$866.24 Million
Basic Average Shares$82.68 Million
Cost Of Revenue$1.51 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Diluted Average Shares$83.47 Million
Income Tax Expense/Benefit$226.87 Million
Diluted Earnings Per Share$10.36
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Income/Loss From Continuing Operations Before Tax$1.09 Billion
Provision For Loan, Lease, And Other Losses$5.17 Million
Income/Loss From Continuing Operations After Tax$866.24 Million
Operating Expenses$1.22 Billion
Operating Income/Loss$1.11 Billion

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Assets$3.35 Billion
Inventory$389.80 Million
Accounts Payable$110.60 Million
Prepaid Expenses$57.22 Million
Current Liabilities$1.01 Billion
Current Assets$1.43 Billion
Equity Attributable To Noncontrolling Interest$0.00
Other Non-current Assets$1.09 Billion
Fixed Assets$717.75 Million
Other Current Assets$986.72 Million
Liabilities And Equity$3.35 Billion
Intangible Assets$106.89 Million
Noncurrent Assets$1.92 Billion
Equity$1.62 Billion
Noncurrent Liabilities$723.49 Million
Liabilities$1.73 Billion
Other Current Liabilities$739.64 Million
Wages$158.99 Million
Equity Attributable To Parent$1.62 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Related Companies

View additional S&P 500 companies similar to Idexx Laboratories Inc (IDXX)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.